Study Evaluating Three Bazedoxifene/Conjugated Estrogens Combination Tablet Formulations Versus BZA Oral Solution
Completed
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 1
2006-08-01
This study involves the experimental drug bazedoxifene acetate/conjugated estrogens (also
called BZA/CE). This drug is not approved by the Food and Drug Administration (FDA).
About 24 subjects will take part in this study. Each subject's participation in this study
will last for about 10 weeks. During this study, each subject will receive 3 different types
of BZA/CE tablets plus an oral solution containing only BZA. The purpose of this study is to
learn how the tablet dosage forms dissolve and are absorbed by the body compared to the BZA
oral solution. In addition, information will also be learned about the safety and
tolerability of these dosage forms given to healthy postmenopausal women.
Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women
Completed
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 1
2006-11-01
The primary objective is to evaluate the bioequivalence between bazedoxifene/conjugated
estrogens tablets produced using the current manufacturing process to bazedoxifene/conjugated
estrogens tablets produced using a new manufacturing process
Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations in Fed and Fasting in Healthy, Postmenopausal Women
Completed
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 1
2007-03-01
The primary objective is to determine the effect of a high-fat meal on the bioavailability
and PK of a single, oral dose of BZA/CE (PNP) 20mg/0.625 strength tablet, assessing both the
BZA and CE components.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
